Abstract

Accurate fusion of late gadolinium enhancement magnetic resonance imaging (MRI) and electro-anatomical voltage mapping (EAM) is required to evaluate the potential of MRI to identify the substrate of ventricular tachycardia. However, both datasets are not acquired at the same cardiac phase and EAM data is corrupted with respiratory motion limiting the accuracy of current rigid fusion techniques. Knowledge of cardiac and respiratory motion during EAM is thus required to enhance the fusion process. In this study, we propose a novel approach to characterize both cardiac and respiratory motion from EAM data using the temporal evolution of the 3D catheter location recorded from clinical EAM systems. Cardiac and respiratory motion components are extracted from the recorded catheter location using multi-band filters. Filters are calibrated for each EAM point using estimates of heart rate and respiratory rate. The method was first evaluated in numerical simulations using 3D models of cardiac and respiratory motions of the heart generated from real time MRI data acquired in 5 healthy subjects. An accuracy of 0.6–0.7 mm was found for both cardiac and respiratory motion estimates in numerical simulations. Cardiac and respiratory motions were then characterized in 27 patients who underwent LV mapping for treatment of ventricular tachycardia. Mean maximum amplitude of cardiac and respiratory motion was 10.2±2.7 mm (min = 5.5, max = 16.9) and 8.8±2.3 mm (min = 4.3, max = 14.8), respectively. 3D Cardiac and respiratory motions could be estimated from the recorded catheter location and the method does not rely on additional imaging modality such as X-ray fluoroscopy and can be used in conventional electrophysiology laboratory setting.

Highlights

  • Catheter-based ventricular tachycardia (VT) ablation significantly reduces and delays the incidence of implantable cardioverter-defibrillator therapy in post myocardial infarction patients [1,2]

  • VT ablation is generally guided by invasive electroanatomical mapping (EAM) of the left ventricle (LV) [3]

  • A 3D shell representing the LV surface, color coded with electrogram characteristics such as bipolar voltage is used for the guidance of the ablation procedure

Read more

Summary

Introduction

Catheter-based ventricular tachycardia (VT) ablation significantly reduces and delays the incidence of implantable cardioverter-defibrillator therapy in post myocardial infarction patients [1,2]. During EAM, a catheter based mapping is performed where intra-cardiac electrograms and catheter tip location are recorded for various point location in the LV. EAM allows identification of the core scar area (bipolar voltage,0.5 mV) and heterogeneous tissues (0.5 mV,bipolar voltage,1.5 mV) which contained the VT substrate. EAM is limited by a low spatial resolution, incorrect voltage values due to imperfect catheter contacts, and its inability to precisely characterize the 3D structure of LV scar. EAM is time-consuming and requires an experienced operator. These limitations could be associated with the low efficacy of the treatment where a recurrence rate of VT episodes has been reported to be up to 50% [1]. A better identification of the VT substrate using alternative approaches may improve the efficacy of VT ablation

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call